Vectura Group
Latest round
- Series B
Last raised
- Apr 2001
Total raised
- $18M
Investors
- 4
About Vectura Group
Based in Chippenham, UK, and founded in 1997, Vectura Group Plc operates as a developer of inhaled therapies for the treatment of respiratory diseases. As of 2021, the company employs around 450 employees and its CEO is Will Downie. In January 2025, Molex, LLC, a portfolio company of Koch Equity Development, acquired Vectura Group Plc. Financial terms of the transaction were not disclosed.
Who invested in Vectura Group
4 investors across 3 rounds
See all investors in Vectura Group
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vectura Group
Who invested in Vectura Group?
Vectura Group has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vectura Group raised?
Vectura Group has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Vectura Group last raise money?
Vectura Group's most recent round on record is a Series B, in Apr 2001.
What does Vectura Group do?
Based in Chippenham, UK, and founded in 1997, Vectura Group Plc operates as a developer of inhaled therapies for the treatment of respiratory diseases.
Where is Vectura Group headquartered?
Vectura Group is headquartered in UK.
Which VCs invest in companies like Vectura Group?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Vectura Group's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Vectura Group? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.